Search results
Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Overview: Surpasses Revenue Estimates
GuruFocus.com via Yahoo Finance· 4 days agoStrategic Developments and Future Outlook Heron Therapeutics has made significant strides in...
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoHeron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript May 7, 2024 Heron ...
FDA to consider MDMA as treatment for PTSD
Becker’s Hospital Review· 4 days agoAn FDA panel of independent advisers is set to consider the first potential new post-traumatic stress disorder treatment in 25 years — MDMA — NBC News reported May 7. MDMA ...
Viridian Therapeutics shares receive reduced price target By Investing.com
Investing.com· 2 days agoOn Thursday, H.C. Wainwright adjusted its price target for shares of Viridian Therapeutics (NASDAQ:...
Q1 2024 Intellia Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoThe study is expected to be a small placebo-controlled trial of approximately 50 patients conducted...
RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Fina
Guru Focus· 1 day agoOn May 9, 2024, RAPT Therapeutics Inc. (RAPT, Financial) released its 8-K filing, detailing the company's financial results for the first quarter ended March 31, 2024. The ...
Travere Therapeutics Inc (TVTX) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...
GuruFocus.com via Yahoo Finance· 5 days agoThe company achieved a 35% growth in revenue over the last quarter, demonstrating robust demand and effective execution by the commercial team. Travere Therapeutics Inc (NASDAQ ...
Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
The Pilot News· 4 days agoTrevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the...
FDA prioritizes review of Merus's cancer therapy Zeno By Investing.com
Investing.com· 5 days agoThe U.S. Food and Drug Administration (FDA) has granted a priority review for the Biologics License...
Anika Therapeutics Inc (ANIK) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
GuruFocus.com via Yahoo Finance· 3 days agoAnika Therapeutics Inc (NASDAQ:ANIK) has made significant progress in its regenerative solutions pipeline, with over 200...using the HA-based integrity implant system and ...